Skip to main content

Bradsher Neal C

In the past year, 7 open-market purchase filings worth $68.4M and no sales.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$68.4M
7 filings
Sold
–
0 filings
Net
+$68.4M
Bought minus sold
Companies
2
With open-market trades

Trades

Every Form 4 that lists Bradsher Neal C as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

IMDX Insight Molecular Diagnostics Inc.

10% Owner16 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 27, 2026 (view filing)7:08 PM ETApr 23-274 daysBroadwood Partners, L.P. and 2 others10% OwnerPPurchaseCommon Stock, no par value+570.2K$3.56+$2.03M+4.7%12.7M after3 lots
Apr 27, 2026 (view filing)7:08 PM ETApr 23-274 daysBroadwood Partners, L.P. and 2 others10% OwnerPPurchaseCommon Stock, no par value0–$00.0%12.7M after3 lots
Apr 20, 2026 (view filing)7:24 PM ETApr 16-204 daysBroadwood Partners, L.P. and 2 others10% OwnerPPurchaseCommon Stock, no par value+182.9K$3.57+$652.9K+1.5%12.1M after3 lots
Apr 20, 2026 (view filing)7:24 PM ETApr 16-204 daysBroadwood Partners, L.P. and 2 others10% OwnerPPurchaseCommon Stock, no par value0–$00.0%12.1M after3 lots
Feb 12, 2026 (view filing)7:49 PM ETFeb 102 daysBroadwood Partners, L.P. and 2 others10% OwnerPPurchaseCommon Stock, no par value+521.7K$5.75+$3.00M+4.6%11.9M after
Feb 12, 2026 (view filing)7:49 PM ETFeb 102 daysBroadwood Partners, L.P. and 2 others10% OwnerPPurchaseCommon Stock, no par value0–$00.0%11.9M after
Feb 10, 2025 (view filing)8:43 PM ETFeb 64 daysBroadwood Partners, L.P. and 2 others10% OwnerPPurchaseCommon Stock, no par value+5.17M$2.05+$10.6M+82.7%11.4M after2 lots
Feb 10, 2025 (view filing)8:43 PM ETFeb 64 daysBroadwood Partners, L.P. and 2 others10% OwnerPPurchaseCommon Stock, no par value0–$00.0%11.4M after2 lots
Oct 4, 2024 (view filing)7:00 PM ETOct 22 daysBroadwood Partners, L.P. and 2 others10% OwnerPPurchaseCommon Stock, no par value+1.32M$2.95+$3.88M+26.7%6.24M after
Oct 4, 2024 (view filing)7:00 PM ETOct 22 daysBroadwood Partners, L.P. and 2 others10% OwnerPPurchaseCommon Stock, no par value0–$00.0%6.24M after

See all 16 trades at IMDX

STAA Staar Surgical Co

Director, 10% Owner52 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 13, 2026 (view filing)7:59 PM ETMar 11-132 daysBroadwood Partners, L.P. and 2 othersDirector, 10% OwnerPPurchase+670.2K$18.30+$12.3M+4.3%16.1M after3 lots
Mar 13, 2026 (view filing)7:59 PM ETMar 11-132 daysBroadwood Partners, L.P. and 2 othersDirector, 10% OwnerPPurchase0–$00.0%16.1M after3 lots
Jan 13, 2026 (view filing)9:30 PM ETJan 94 daysBroadwood Partners, L.P. and 2 others10% OwnerPPurchase+27.5K$22.05+$606.1K+0.2%15.5M after
Jan 13, 2026 (view filing)9:30 PM ETJan 94 daysBroadwood Partners, L.P. and 2 others10% OwnerPPurchase0–$00.0%15.5M after
Jan 8, 2026 (view filing)7:31 PM ETJan 6-82 daysBroadwood Partners, L.P. and 2 others10% OwnerPPurchase+406.7K$21.68+$8.82M+2.7%15.4M after4 lots
Jan 8, 2026 (view filing)7:31 PM ETJan 6-82 daysBroadwood Partners, L.P. and 2 others10% OwnerPPurchase0–$00.0%15.4M after4 lots
Nov 21, 2025 (view filing)9:55 PM ETNov 19-212 daysBroadwood Partners, L.P. and 2 others10% OwnerPPurchase+1.50M$27.37+$41.1M+11.1%15.0M after3 lots
Nov 21, 2025 (view filing)9:55 PM ETNov 19-212 daysBroadwood Partners, L.P. and 2 others10% OwnerPPurchase0–$00.0%15.0M after3 lots
Apr 10, 2025 (view filing)7:00 PM ETApr 8-102 daysBroadwood Partners, L.P. and 2 others10% OwnerPPurchase+187.2K$15.31+$2.87M+1.4%13.5M after4 lots
Apr 10, 2025 (view filing)7:00 PM ETApr 8-102 daysBroadwood Partners, L.P. and 2 others10% OwnerPPurchase0–$00.0%13.5M after4 lots

See all 52 trades at STAA

LCTX Lineage Cell Therapeutics, Inc.

Director, 10% Owner8 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 28, 2025 (view filing)7:49 PM ETJan 271 dayBroadwood Partners, L.P. and 2 othersDirector, 10% OwnerPPurchase+7.89M$0.76+$6.00M+18.9%49.6M after
Jan 28, 2025 (view filing)7:49 PM ETJan 271 dayBroadwood Partners, L.P. and 2 othersDirector, 10% OwnerPPurchase0–$00.0%49.6M after
Jan 28, 2025 (view filing)7:49 PM ETJan 271 dayBroadwood Partners, L.P. and 2 othersDirector, 10% OwnerPPurchase+7.89M$0.00$0–7.89M afterDerivative
Jan 28, 2025 (view filing)7:49 PM ETJan 271 dayBroadwood Partners, L.P. and 2 othersDirector, 10% OwnerPPurchase+7.89M$0.00$0–7.89M afterDerivative
Feb 8, 2024 (view filing)6:58 PM ETFeb 62 daysBroadwood Partners, L.P. and 2 othersDirector, 10% OwnerPPurchase+6.73M$1.04+$7.00M+19.3%41.7M after
Feb 8, 2024 (view filing)6:58 PM ETFeb 62 daysBroadwood Partners, L.P. and 2 othersDirector, 10% OwnerPPurchase0–$00.0%41.7M after
Mar 25, 2022 (view filing)5:56 PM ETMar 23-252 daysBroadwood Partners, L.P. and 2 othersDirector, 10% OwnerPPurchase+930.1K$1.42+$1.32M+2.7%34.9M after3 lots
Mar 25, 2022 (view filing)5:56 PM ETMar 23-252 daysBroadwood Partners, L.P. and 2 othersDirector, 10% OwnerPPurchase0–$00.0%34.9M after3 lots